• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

AcouSort invited to key marketing and partnering events in Japan

ACOUPress release2026-06-29 09:00

AcouSort has for the third time been invited by the EU Business Hub to participate in marketing and partnering events in East Asia – this time in Osaka, Japan, July 1-4 2026.

“For AcouSort, participation in the EU Business Hub provides a great opportunity to meet and connect with Japanese companies active within our target markets. We are absolutely thrilled to be part of these very dynamic events,” said Torsten Freltoft, CEO at AcouSort.

The EU Business Hub is a programme funded by the European Union in support of EU Small and Medium-sized Enterprises (SMEs) and startups within the green, digital, and healthcare sectors that seek business opportunities and establish partnerships in Japan and the Republic of Korea (RoK).

AcouSort will participate at two separate events held in Osaka, Japan:

At HealthX Connect Osaka 2026 on July 1, 40 invited European companies can meet relevant potential partners/customers from the greater Osaka area. AcouSort will be part of an on-site business matching event, offering participants the opportunity to meet directly with representatives from the healthcare, biotechnology and pharmaceutical industries in Osaka. The company is also invited to give a short pitch presentation of its technology and offerings at this event.

World Health Expo Osaka (WHX) (July 2-4) is a three-day international gathering exploring Medical diagnostics, advanced healthcare technologies, and next-generation medicine driven by AI and robotics – bringing together global healthcare leaders and innovators.

The EU Business HUB has a large booth with space for all 40 invited companies. In addition, there is a formalized partnering platform where meetings can be pre-arranged with other participants of WHX.

FOR FURTHER INFORMATION ABOUT ACOUSORT, PLEASE CONTACT:
Torsten Freltoft, CEO
Telephone: +45 2045 0854
E-mail: torsten.freltoft@acousort.com

ABOUT ACOUSORT
AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify, and stain cells, exosomes, and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing – so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases, and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company’s Certified Adviser is Tapper Partners AB.

Attachments
AcouSort invited to key marketing and partnering events in Japan